Correlation between CAG repeat length and clinical features in Machado-Joseph disease.

The likelihood of being affected with Huntington disease by a particular age, for a specific CAG size. Am J Hum Genet (1997) 2.84

The natural history of spinocerebellar ataxia type 1, 2, 3, and 6: a 2-year follow-up study. Neurology (2011) 2.06

Hereditary spastic paraparesis: a review of new developments. J Neurol Neurosurg Psychiatry (2000) 1.87

Toward understanding Machado-Joseph disease. Prog Neurobiol (2011) 1.42

The prevalence and wide clinical spectrum of the spinocerebellar ataxia type 2 trinucleotide repeat in patients with autosomal dominant cerebellar ataxia. Am J Hum Genet (1997) 1.35

Machado-Joseph Disease: from first descriptions to new perspectives. Orphanet J Rare Dis (2011) 1.18

Milestones in ataxia. Mov Disord (2011) 1.11

Machado-Joseph disease/spinocerebellar ataxia type 3. Handb Clin Neurol (2012) 1.09

Consensus paper: pathological mechanisms underlying neurodegeneration in spinocerebellar ataxias. Cerebellum (2014) 1.03

Relations between genotype and phenotype in German patients with the Machado-Joseph disease mutation. J Neurol Neurosurg Psychiatry (1996) 1.02

Japanese families with autosomal dominant pure cerebellar ataxia map to chromosome 19p13.1-p13.2 and are strongly associated with mild CAG expansions in the spinocerebellar ataxia type 6 gene in chromosome 19p13.1. Am J Hum Genet (1997) 0.96

Autosomal dominant pure spastic paraplegia: a clinical, paraclinical, and genetic study. J Neurol Neurosurg Psychiatry (1998) 0.93

The genetic defect causing Huntington's disease: repeated in other contexts? Mol Med (1997) 0.90

A familial factor independent of CAG repeat length influences age at onset of Machado-Joseph disease. Am J Hum Genet (1996) 0.90

High germinal instability of the (CTG)n at the SCA8 locus of both expanded and normal alleles. Am J Hum Genet (2000) 0.89

Increased transcript diversity: novel splicing variants of Machado-Joseph disease gene (ATXN3). Neurogenetics (2009) 0.88

The role of the immune system in triplet repeat expansion diseases. Mediators Inflamm (2015) 0.85

Modifiers of (CAG)(n) instability in Machado-Joseph disease (MJD/SCA3) transmissions: an association study with DNA replication, repair and recombination genes. Hum Genet (2014) 0.84

Nucleation of protein aggregation kinetics as a basis for genotype-phenotype correlations in polyglutamine diseases. Mol Neurodegener (2009) 0.83

Consensus and controversies in best practices for molecular genetic testing of spinocerebellar ataxias. Eur J Hum Genet (2010) 0.83

Different origins of mutations at the Machado-Joseph locus (MJD1) J Med Genet (1996) 0.82

Therapeutic prospects for spinocerebellar ataxia type 2 and 3. Drugs Future (2009) 0.82

Normal ATXN3 Allele but Not CHIP Polymorphisms Modulates Age at Onset in Machado-Joseph Disease. Front Neurol (2012) 0.81

Ataxin-3 protein and RNA toxicity in spinocerebellar ataxia type 3: current insights and emerging therapeutic strategies. Mol Neurobiol (2013) 0.81

Two novel SNPs in ATXN3 3' UTR may decrease age at onset of SCA3/MJD in Chinese patients. PLoS One (2015) 0.80

The (CAG)n tract of Machado-Joseph Disease gene (ATXN3): a comparison between DNA and mRNA in patients and controls. Eur J Hum Genet (2009) 0.80

Mutation detection in Machado-Joseph disease using repeat expansion detection. Mol Med (1996) 0.79

Psychological well-being and family satisfaction levels five years after being confirmed as a carrier of the Machado-Joseph disease mutation. Genet Test Mol Biomarkers (2012) 0.78

Investigation of the Josephin Domain protein-protein interaction by molecular dynamics. PLoS One (2014) 0.77

Josephin Domain Structural Conformations Explored by Metadynamics in Essential Coordinates. PLoS Comput Biol (2016) 0.76

Caloric restriction blocks neuropathology and motor deficits in Machado-Joseph disease mouse models through SIRT1 pathway. Nat Commun (2016) 0.76

Quantitative connection between polyglutamine aggregation kinetics and neurodegenerative process in patients with Huntington's disease. Mol Neurodegener (2012) 0.76

Fibroblasts of Machado Joseph Disease patients reveal autophagy impairment. Sci Rep (2016) 0.76

Genotype-phenotype correlation in Chinese patients with spinal and bulbar muscular atrophy. PLoS One (2015) 0.76

Spinocerebellar ataxia type 3/Machado-Joseph disease manifested as spastic paraplegia: A clinical and genetic study. Exp Ther Med (2014) 0.75

The role of apolipoprotein E as a risk factor for an earlier age at onset for Machado-Joseph disease is doubtful. PLoS One (2014) 0.75

Alleviating neurodegeneration in Drosophila models of PolyQ diseases. Cerebellum Ataxias (2014) 0.75

Patterns of motor signs in spinocerebellar ataxia type 3 at the start of follow-up in a reference unit. Cerebellum Ataxias (2016) 0.75

CAG repeat length does not associate with the rate of cerebellar degeneration in spinocerebellar ataxia type 3. Neuroimage Clin (2016) 0.75

Thermodynamic and kinetic stability of the Josephin Domain closed arrangement: evidences from replica exchange molecular dynamics. Biol Direct (2017) 0.75

Large normal-range TBP and ATXN7 CAG repeat lengths are associated with increased lifetime risk of depression. Transl Psychiatry (2017) 0.75

Use of cyclosporin A in establishing Epstein-Barr virus-transformed human lymphoblastoid cell lines. In Vitro (1984) 7.23

CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1. Nat Genet (1994) 7.07

Trinucleotide repeat length instability and age of onset in Huntington's disease. Nat Genet (1993) 6.53

The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington's disease. Nat Genet (1993) 5.82

Relationship between trinucleotide repeat expansion and phenotypic variation in Huntington's disease. Nat Genet (1993) 5.70

Unstable expansion of CAG repeat in hereditary dentatorubral-pallidoluysian atrophy (DRPLA). Nat Genet (1994) 4.36

Evidence for a mechanism predisposing to intergenerational CAG repeat instability in spinocerebellar ataxia type I. Nat Genet (1993) 3.28

Length of uninterrupted CGG repeats determines instability in the FMR1 gene. Nat Genet (1994) 3.22

Molecular analysis of new mutations for Huntington's disease: intermediate alleles and sex of origin effects. Nat Genet (1993) 3.04

Size of the unstable CTG repeat sequence in relation to phenotype and parental transmission in myotonic dystrophy. Am J Hum Genet (1993) 2.42

Somatic and gonadal mosaicism of the Huntington disease gene CAG repeat in brain and sperm. Nat Genet (1994) 2.31

Meiotic stability and genotype-phenotype correlation of the trinucleotide repeat in X-linked spinal and bulbar muscular atrophy. Nat Genet (1992) 2.18

The gene for Machado-Joseph disease maps to human chromosome 14q. Nat Genet (1993) 2.18

Myotonic dystrophy: size- and sex-dependent dynamics of CTG meiotic instability, and somatic mosaicism. Am J Hum Genet (1993) 1.86

Mutational bias provides a model for the evolution of Huntington's disease and predicts a general increase in disease prevalence. Nat Genet (1994) 1.71

Autosomal dominant system degeneration in Portuguese families of the Azores Islands. A new genetic disorder involving cerebellar, pyramidal, extrapyramidal and spinal cord motor functions. Neurology (1978) 1.66

Huntington disease without CAG expansion: phenocopies or errors in assignment? Am J Hum Genet (1994) 1.53

Epidemiology and clinical aspects of Machado-Joseph disease. Adv Neurol (1993) 1.41

Molecular and clinical correlations in spinocerebellar ataxia type I: evidence for familial effects on the age at onset. Am J Hum Genet (1994) 1.38

Autosomal dominant striatonigral degeneration. A clinical, pathologic, and biochemical study of a new genetic disorder. Neurology (1976) 1.27

Clinical criteria for diagnosis of Machado-Joseph disease: report of a non-Azorena Portuguese family. Neurology (1980) 1.27

Intergenerational stability of the myotonic dystrophy protomutation. Hum Mol Genet (1993) 1.19

Effect of trinucleotide repeat length and parental sex on phenotypic variation in spinocerebellar ataxia I. Am J Hum Genet (1994) 1.13

The pathology of Machado-Joseph disease. Report of a possible homozygous case. Acta Neuropathol (1982) 1.04

Machado-Joseph disease in New England: clinical description and distinction from the olivopontocerebellar atrophies. Mov Disord (1992) 1.03

Joseph disease in a non-Portuguese family. Neurology (1983) 0.96

Type III Machado-Joseph disease in a Japanese family: a clinicopathological study with special reference to the peripheral nervous system. Clin Neuropathol (1989) 0.92

Genetic linkage studies of Machado-Joseph disease with chromosome 14q STRPs in 16 Portuguese-Azorean kindreds. Genomics (1994) 0.89

Evidence for a gene influencing blood pressure on chromosome 17. Genome scan linkage results for longitudinal blood pressure phenotypes in subjects from the framingham heart study. Hypertension (2000) 8.84

Mutations in the APC tumour suppressor gene cause chromosomal instability. Nat Cell Biol (2001) 4.90

International Cooperative Ataxia Rating Scale for pharmacological assessment of the cerebellar syndrome. The Ataxia Neuropharmacology Committee of the World Federation of Neurology. J Neurol Sci (1997) 4.50

The gene mutated in ataxia-ocular apraxia 1 encodes the new HIT/Zn-finger protein aprataxin. Nat Genet (2001) 3.01

Double-blind pilot trial of oral tolerization with myelin antigens in multiple sclerosis. Science (1993) 2.97

Intensive immunosuppression in progressive multiple sclerosis. A randomized, three-arm study of high-dose intravenous cyclophosphamide, plasma exchange, and ACTH. N Engl J Med (1983) 2.93

Recessive ataxia with ocular apraxia: review of 22 Portuguese patients. Arch Neurol (2001) 2.89

The comparative enzymology of creatine kinases. I. Isolation and characterization from chicken and rabbit tissues. J Biol Chem (1967) 2.54

Spectrum of SPG4 mutations in autosomal dominant spastic paraplegia. Hum Mol Genet (2000) 2.40

Haplotypes and gene expression implicate the MAPT region for Parkinson disease: the GenePD Study. Neurology (2008) 2.16

Prospective study of infection, colonization and carriage of methicillin-resistant Staphylococcus aureus in an outbreak affecting 990 patients. Eur J Clin Microbiol Infect Dis (1994) 2.04

Evidence for a gene influencing the TG/HDL-C ratio on chromosome 7q32.3-qter: a genome-wide scan in the Framingham study. Hum Mol Genet (2000) 1.94

Ataxia with oculomotor apraxia type 2: clinical, biological and genotype/phenotype correlation study of a cohort of 90 patients. Brain (2009) 1.91

A mutation in the Gsk3-binding domain of zebrafish Masterblind/Axin1 leads to a fate transformation of telencephalon and eyes to diencephalon. Genes Dev (2001) 1.90

Mitochondrial neurogastrointestinal encephalomyopathy: an autosomal recessive disorder due to thymidine phosphorylase mutations. Ann Neurol (2000) 1.82

Intermittent cyclophosphamide pulse therapy in progressive multiple sclerosis: final report of the Northeast Cooperative Multiple Sclerosis Treatment Group. Neurology (1993) 1.81

Systematic resequencing of X-chromosome synaptic genes in autism spectrum disorder and schizophrenia. Mol Psychiatry (2010) 1.69

Mapping of the hypokalaemic periodic paralysis (HypoPP) locus to chromosome 1q31-32 in three European families. Nat Genet (1994) 1.67

Autosomal dominant system degeneration in Portuguese families of the Azores Islands. A new genetic disorder involving cerebellar, pyramidal, extrapyramidal and spinal cord motor functions. Neurology (1978) 1.66

Risk factors for developing clinical infection with methicillin-resistant Staphylococcus aureus (MRSA) amongst hospital patients initially only colonized with MRSA. J Hosp Infect (1997) 1.64

Treatment of action tremor in multiple sclerosis with isoniazid. Neurology (1982) 1.53

Strong constraints on the rare decays B(s)(0) → μ+ μ- and B0 → μ+ μ-. Phys Rev Lett (2012) 1.50

First observation of the decays B(0) → D(+)K(-)π(+)π(-) and B(-) → D(0)K(-)π(+)π(-). Phys Rev Lett (2012) 1.50

CNS involvement in the non-Hodgkin's lymphomas. Cancer (1980) 1.49

Th1 and th2 cytokine expression in nasopharyngeal secretions during acute bronchiolitis in children younger than two years old. Allergol Immunopathol (Madr) (2010) 1.43

Determination of the X(3872) meson quantum numbers. Phys Rev Lett (2013) 1.42

Epidemiology and clinical aspects of Machado-Joseph disease. Adv Neurol (1993) 1.41

Recessive ataxia with ocular motor apraxia. Arch Neurol (2001) 1.39

[The secondary prevention of coronary disease: ACE inhibitors, adrenergic beta-blockers and statins for everyone? The arguments con]. Rev Port Cardiol (2000) 1.37

Frequency of spinocerebellar ataxia type 1, dentatorubropallidoluysian atrophy, and Machado-Joseph disease mutations in a large group of spinocerebellar ataxia patients. Neurology (1996) 1.36

The comparative enzymology of creatine kinases. II. Physical and chemical properties. J Biol Chem (1967) 1.31

APOE epsilon4 is associated with obstructive sleep apnea/hypopnea: the Sleep Heart Health Study. Neurology (2004) 1.28

Common variants in the 5' region of the leptin gene are associated with body mass index in men from the National Heart, Lung, and Blood Institute Family Heart Study. Am J Hum Genet (2004) 1.27

Clinical criteria for diagnosis of Machado-Joseph disease: report of a non-Azorena Portuguese family. Neurology (1980) 1.27

Trinucleotide repeats in 202 families with ataxia: a small expanded (CAG)n allele at the SCA17 locus. Arch Neurol (2002) 1.26

Hypokalemic periodic paralysis with arrhythmia. N Engl J Med (1972) 1.25

Molecular and clinical correlations in spinocerebellar ataxia 2: a study of 32 families. Hum Mol Genet (1997) 1.24

Neuroferritinopathy: missense mutation in FTL causing early-onset bilateral pallidal involvement. Neurology (2005) 1.23

Creatine kinase: evidence for a dimeric structure. Biochem Biophys Res Commun (1965) 1.21

First observation of CP violation in the decays of B(s)0 mesons. Phys Rev Lett (2013) 1.21

Clinical heterogeneity of autosomal recessive spastic paraplegias: analysis of 106 patients in 46 families. Arch Neurol (1999) 1.16

Hereditary ataxias and spastic paraplegias: methodological aspects of a prevalence study in Portugal. J Clin Epidemiol (1997) 1.11

Gait disorders among elderly patients. A survey study of 50 patients. Arch Neurol (1983) 1.10

Immunologic responses of progressive multiple sclerosis patients treated with an anti-T-cell monoclonal antibody, anti-T12. Neurology (1986) 1.09

CAG repeat length in RAI1 is associated with age at onset variability in spinocerebellar ataxia type 2 (SCA2). Hum Mol Genet (2000) 1.09

Creatin kinase in human tissues. Arch Neurol (1967) 1.08

Machado disease. A hereditary ataxia in Portuguese emigrants to Massachusetts. Neurology (1972) 1.07

Improvement in the molecular diagnosis of Machado-Joseph disease. Arch Neurol (2001) 1.07

Ancestral origins of the Machado-Joseph disease mutation: a worldwide haplotype study. Am J Hum Genet (2000) 1.06

Phenotype of autosomal dominant spastic paraplegia linked to chromosome 2. Brain (1996) 1.06

The pathology of Machado-Joseph disease. Report of a possible homozygous case. Acta Neuropathol (1982) 1.04

Linkage of congenital recessive deafness (gene DFNB10) to chromosome 21q22.3. Am J Hum Genet (1996) 1.04

Homozygosity mapping of Portuguese and Japanese forms of ataxia-oculomotor apraxia to 9p13, and evidence for genetic heterogeneity. Am J Hum Genet (2001) 1.03

SPG15 is the second most common cause of hereditary spastic paraplegia with thin corpus callosum. Neurology (2009) 1.03

Herpes simplex meningitis: isolation of herpes simplex virus type 2 from cerebrospinal fluid. N Engl J Med (1973) 1.03

Machado-Joseph disease in New England: clinical description and distinction from the olivopontocerebellar atrophies. Mov Disord (1992) 1.03

Depressive symptoms in Machado-Joseph disease (SCA3) patients and their relatives. Community Genet (2007) 1.03

Familial paragangliomas: linkage to chromosome 11q23 and clinical implications. Am J Med Genet (1997) 1.02

Absence of previously reported variants in the SCNA (G88C and G209A), NR4A2 (T291D and T245G) and the DJ-1 (T497C) genes in familial Parkinson's disease from the GenePD study. Mov Disord (2005) 1.01

Neurologic findings in Machado-Joseph disease: relation with disease duration, subtypes, and (CAG)n. Arch Neurol (2001) 1.00

Machado-Joseph disease gene products carrying different carboxyl termini. Neurosci Res (1997) 1.00

Fibrin deposition in Peyronie's disease plaque. J Urol (1997) 0.99

Somatic mosaicism in the central nervous system in spinocerebellar ataxia type 1 and Machado-Joseph disease. Ann Neurol (1996) 0.99

Joseph's disease: an autosomal dominant neurological disease in the Portuguese of the United States and the Azores Islands. Adv Neurol (1978) 0.97

The natural history of Machado-Joseph disease. An analysis of 138 personally examined cases. Can J Neurol Sci (1984) 0.97

The prevalence of mycotoxins in Kashin-Beck disease. Int Orthop (2001) 0.97

Treatment of stiff-man syndrome with intravenous immune globulin. Arthritis Rheum (1994) 0.97

Measurement of form-factor-independent observables in the decay B0→K(*0)μ(+)μ(-). Phys Rev Lett (2013) 0.96

Whipple's disease confined to the brain: a case studied clinically and pathologically. J Neurol Neurosurg Psychiatry (1977) 0.96

Autosomal dominant cerebellar ataxia: frequency analysis and clinical characterization of 45 families from Portugal. Eur J Neurol (2009) 0.96

Rickettsial infections of dogs, horses and ticks in Juiz de Fora, southeastern Brazil, and isolation of Rickettsia rickettsii from Rhipicephalus sanguineus ticks. Med Vet Entomol (2010) 0.95

Observation of a resonance in B+ → K+ μ+ μ- decays at low recoil. Phys Rev Lett (2013) 0.95

Azorean disease of the nervous system. N Engl J Med (1977) 0.95

Evidence for linkage between essential hypertension and a putative locus on human chromosome 17. Hypertension (1999) 0.94

Multiple molecular forms of creatine kinases. Ann N Y Acad Sci (1968) 0.94

The Machado-Joseph disease locus is different from the spinocerebellar ataxia locus (SCA1). Genomics (1992) 0.94

Machado-Joseph disease. Clin Neurosci (1995) 0.93

Population genetics of wild-type CAG repeats in the Machado-Joseph disease gene in Portugal. Hum Hered (2005) 0.93

The use of cyclophosphamide in the treatment of multiple sclerosis. Ann N Y Acad Sci (1984) 0.92

McArdle's disease: lack of muscle phosphorylase. Ann Intern Med (1968) 0.92

Linkage disequilibrium analysis in Machado-Joseph disease patients of different ethnic origins. Hum Genet (1996) 0.91

Treatment of progressive multiple sclerosis with pulse cyclophosphamide/methylprednisolone: response to therapy is linked to the duration of progressive disease. Mult Scler (1999) 0.90

A double-blind, randomized, placebo-controlled clinical trial to evaluate the safety and efficacy of mupirocin calcium ointment for eliminating nasal carriage of Staphylococcus aureus among hospital personnel. J Antimicrob Chemother (1995) 0.90

A familial factor independent of CAG repeat length influences age at onset of Machado-Joseph disease. Am J Hum Genet (1996) 0.90

The cervical myelopathy associated with rheumatoid arthritis: analysis of patients, with 2 postmortem cases. Ann Neurol (1978) 0.90

BDNF genetic variants are associated with onset age of familial Parkinson disease: GenePD Study. Neurology (2005) 0.90

A haplotype at the PARK3 locus influences onset age for Parkinson's disease: the GenePD study. Neurology (2003) 0.90